Johnson & Johnson (JNJ) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $8.0 billion.
- Johnson & Johnson's Cost of Revenue rose 1178.45% to $8.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $30.3 billion, marking a year-over-year increase of 1013.8%. This contributed to the annual value of $30.3 billion for FY2025, which is 1013.8% up from last year.
- As of Q4 2025, Johnson & Johnson's Cost of Revenue stood at $8.0 billion, which was up 1178.45% from $7.3 billion recorded in Q3 2025.
- In the past 5 years, Johnson & Johnson's Cost of Revenue registered a high of $8.0 billion during Q4 2025, and its lowest value of $2.7 billion during Q1 2023.
- Over the past 5 years, Johnson & Johnson's median Cost of Revenue value was $7.1 billion (recorded in 2021), while the average stood at $6.9 billion.
- Data for Johnson & Johnson's Cost of Revenue shows a peak YoY increase of 15215.13% (in 2023) and a maximum YoY decrease of 1839.88% (in 2023) over the last 5 years.
- Johnson & Johnson's Cost of Revenue (Quarter) stood at $7.3 billion in 2021, then fell by 14.87% to $6.2 billion in 2022, then rose by 10.14% to $6.8 billion in 2023, then grew by 4.85% to $7.1 billion in 2024, then increased by 11.78% to $8.0 billion in 2025.
- Its last three reported values are $8.0 billion in Q4 2025, $7.3 billion for Q3 2025, and $7.6 billion during Q2 2025.